Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17498929rdf:typepubmed:Citationlld:pubmed
pubmed-article:17498929lifeskim:mentionsumls-concept:C1457887lld:lifeskim
pubmed-article:17498929lifeskim:mentionsumls-concept:C1333336lld:lifeskim
pubmed-article:17498929lifeskim:mentionsumls-concept:C0033975lld:lifeskim
pubmed-article:17498929lifeskim:mentionsumls-concept:C0439793lld:lifeskim
pubmed-article:17498929lifeskim:mentionsumls-concept:C0332189lld:lifeskim
pubmed-article:17498929lifeskim:mentionsumls-concept:C1446409lld:lifeskim
pubmed-article:17498929lifeskim:mentionsumls-concept:C1306673lld:lifeskim
pubmed-article:17498929lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:17498929lifeskim:mentionsumls-concept:C0332514lld:lifeskim
pubmed-article:17498929pubmed:issue1-3lld:pubmed
pubmed-article:17498929pubmed:dateCreated2007-6-4lld:pubmed
pubmed-article:17498929pubmed:abstractTextThe amplitude of the P300 event-related potential (ERP) has been reported to be reduced over left compared to right temporal sites in schizophrenia patients. This left temporal P300 reduction has been associated with positive symptom severity and gray matter reduction in the left superior temporal gyrus. We investigated a group of patients with a first episode of schizophrenia spectrum psychosis and a group of normal controls to verify if P300 amplitude asymmetry already exists around the time of presentation for treatment. Relative to normal control subjects, no P300 asymmetry was found in patients. Nevertheless, P300 asymmetry was correlated with the severity of positive symptoms and worse global functioning (GAF), a good predictor of poor outcome.lld:pubmed
pubmed-article:17498929pubmed:languageenglld:pubmed
pubmed-article:17498929pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17498929pubmed:citationSubsetIMlld:pubmed
pubmed-article:17498929pubmed:statusMEDLINElld:pubmed
pubmed-article:17498929pubmed:monthJullld:pubmed
pubmed-article:17498929pubmed:issn0920-9964lld:pubmed
pubmed-article:17498929pubmed:authorpubmed-author:JooberRidhaRlld:pubmed
pubmed-article:17498929pubmed:authorpubmed-author:PrévostMarieMlld:pubmed
pubmed-article:17498929pubmed:authorpubmed-author:DebruilleJ...lld:pubmed
pubmed-article:17498929pubmed:authorpubmed-author:MallaAshokAlld:pubmed
pubmed-article:17498929pubmed:authorpubmed-author:BrodeurMathie...lld:pubmed
pubmed-article:17498929pubmed:authorpubmed-author:LionnetClaire...lld:pubmed
pubmed-article:17498929pubmed:authorpubmed-author:RenoultLouisLlld:pubmed
pubmed-article:17498929pubmed:issnTypePrintlld:pubmed
pubmed-article:17498929pubmed:volume93lld:pubmed
pubmed-article:17498929pubmed:ownerNLMlld:pubmed
pubmed-article:17498929pubmed:authorsCompleteYlld:pubmed
pubmed-article:17498929pubmed:pagination366-73lld:pubmed
pubmed-article:17498929pubmed:dateRevised2010-9-2lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:meshHeadingpubmed-meshheading:17498929...lld:pubmed
pubmed-article:17498929pubmed:year2007lld:pubmed
pubmed-article:17498929pubmed:articleTitleP300 asymmetry and positive symptom severity: a study in the early stage of a first episode of psychosis.lld:pubmed
pubmed-article:17498929pubmed:affiliationDepartment of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada.lld:pubmed
pubmed-article:17498929pubmed:publicationTypeJournal Articlelld:pubmed